In Other News

• Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

• Label-Free Microfluidic Device Enriches Tumor Cells and Clusters from Pleural Effusions

• Tumor Immune Structure Predicts Response to Immunotherapy in Melanoma

• Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

• Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

• Tumor Immune Structure Predicts Response to Immunotherapy in Melanoma

• Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

• Plug-and-Play AI Pathology System Classifies Multiple Cancers from Few Slides

• Cancer-Related Mutations in Immune Cells Linked to Alzheimer’s

• Oral–Gut Microbiome Signatures Identify Early Gastric Cancer

• AI-Based Assays Support Risk Stratification in Prostate and Breast Cancer

• Microneedle Sensor Enables Continuous Monitoring of Drug Clearance

• Label-Free Microscopy Methodd Enables Faster, Quantitative Detection of Malaria

• Composite Blood Biomarkers Enable Early Detection of Common Cancers

• Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching

• Cancer-Related Mutations in Immune Cells Linked to Alzheimer’s

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• AI Pathology Model Predicts Immunotherapy Response in Lung Cancer

• Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

• Blood Test Enables Early Detection and Classification of Glioma

• Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation